Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2004 Dec 11;329(7479):1369-73.
doi: 10.1136/bmj.38281.595718.7C. Epub 2004 Nov 18.

Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials

Ian Colman  1 , Michael D Brown, Grant D Innes, Eric Grafstein, Ted E Roberts, Brian H Rowe
Affiliations
Meta-Analysis

Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials

Ian Colman et al. BMJ. .

Abstract

Objective: To assess the evidence from controlled trials on the efficacy and tolerability of parenteral metoclopramide for acute migraine in adults.

Data sources: Cochrane Central Register of Controlled Trials, Medline, Embase, LILACS, CINAHL, conference proceedings, clinical practice guidelines, and other sources.

Selection criteria: Randomised controlled trials of parenteral metoclopramide for acute migraine in adults.

Results: We reviewed 596 potentially relevant abstracts and found 13 eligible trials totalling 655 adults. In studies comparing metoclopramide with placebo, metoclopramide was more likely to provide significant reduction in migraine pain (odds ratio 2.84, 95% confidence interval 1.05 to 7.68). Used as the only agent, metoclopramide showed mixed effectiveness when compared with other single agents. Heterogeneity of studies for combination treatment prevented statistical pooling. Treatments that did include metoclopramide were as, or more, effective than comparison treatments for pain, nausea, and relapse outcomes reported in all studies.

Conclusions: Metoclopramide is an effective treatment for migraine headache and may be effective when combined with other treatments. Given its non-narcotic and antiemetic properties, metoclopramide should be considered a primary agent in the treatment of acute migraines in emergency departments.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Identification of potentially relevant studies in review
Fig 2
Fig 2
Metoclopramide compared with placebo in reducing pain from acute migraine
Fig 3
Fig 3
Metoclopramide combined with other agents compared with other agents in reducing pain from acute migraine
See this image and copyright information in PMC

Comment in

References

    1. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence: a review of population-based studies. Neurology 1994;44(Suppl 4): S17-23. - PubMed
    1. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999;159: 813-8. - PubMed
    1. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 1993;20: 131-7. - PubMed
    1. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55: 754-62. - PubMed
    1. Pryse-Phillips WE, Dodick DW, Edmeads JG, Gawel MJ, Nelson RF, Purdy RA, et al. Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society. CMAJ 1997;156: 1273-87. - PMC - PubMed

Publication types

MeSH terms